Secondary Logo

Journal Logo

Public Reporting of Cardiac Outcomes for Patients With Acute Myocardial Infarction

A Systematic Review of the Evidence

de Cordova, Pamela B., PhD, RN-BC; Johansen, Mary L., PhD, NE-BC, RN; Riman, Kathryn A., BS, RN; Rogowski, Jeannette, PhD

Journal of Cardiovascular Nursing: March/April 2019 - Volume 34 - Issue 2 - p 115–123
doi: 10.1097/JCN.0000000000000524
ARTICLES: Risk Detection and Reduction

Background: Percutaneous coronary intervention (PCI) is recognized by both the American Heart Association and the American College of Cardiology as an optimal therapy to treat patients experiencing acute myocardial infarction (AMI) with ST-segment elevation myocardial infarction. A health policy aimed at improving outcomes for the patient with AMI is public reporting of whether a patient received a PCI.

Objective: A systematic review was conducted to evaluate the effect of public reporting for patients with AMI, specifically for those patients who receive PCI.

Methods: EMBASE, MEDLINE, Academic Search Premier, Google Scholar, and PubMed were searched from inception through August 2017. Articles were selected for inclusion if researchers evaluated public reporting and included an outcome for whether a patient received a PCI during hospitalization for an AMI. Methodological quality of the included studies was evaluated, and findings were synthesized.

Results: Eight studies of high methodological quality were included in the review. Most studies found that, in areas of public reporting, patients were less likely to undergo a PCI and high-risk patients did not undergo a PCI. Researchers also found that patients with AMI had lower in-hospital mortality after the implementation of public reporting, but only if these patients received a PCI.

Conclusions: Although public reporting may have had intentions of improving care, there is strong evidence that this policy did not result in more timely PCIs or improved mortality of patients with AMI. In fact, public reporting resulted in unintended consequences of not providing care for the most vulnerable patients in fear of an adverse outcome.

Pamela B. de Cordova, PhD, RN-BC Assistant Professor, Research Faculty, New Jersey Collaborating Center for Nursing, Rutgers, the State University of New Jersey, Newark.

Mary L. Johansen PhD, NE-BC, RN Clinical Associate Professor and Associate Director, New Jersey Collaborating Center for Nursing, Rutgers, the State University of New Jersey, Newark.

Kathryn A. Riman BS, RN Undergraduate Honors Nursing Student, Rutgers, the State University of New Jersey, Newark.

Jeannette Rogowski PhD University Professor, Rutgers, the State University of New Jersey, New Brunswick.

Funding has been received to complete this work from the Agency for Healthcare Research and Quality (1K08HS024339-01A1) Mentored Clinical Scientist Research Career Development Award.

The authors have no conflicts of interest to disclose.

Correspondence Pamela B. de Cordova, PhD, RN-BC, Research Faculty, New Jersey Collaborating Center for Nursing, Rutgers, the State University of New Jersey, 180 University Ave, Room 244, Newark, NJ 07102 (

According to the American Heart Association, an acute myocardial infarction (AMI) occurs approximately every 40 seconds affecting more than 750000 Americans annually.1 It is the fifth most expensive condition treated in US hospitals accounting for approximately one-fifth of the total aggregate costs for all hospitalizations.1–3 Extensive strides have been made in treatment for the patient with AMI, which include interventions such as thrombolytics and percutaneous coronary intervention (PCI). These forms of treatment are recognized by both the American Heart Association and the American College of Cardiology as optimal therapies to treat patients with AMI, especially those with ST-segment elevation myocardial infarction.1 Timely reperfusion of the coronary arteries by balloon inflation within 90 minutes of arrival4 has been linked to improved outcomes including a high percentage of lasting reperfusions, lower rates of complications, decreased hospital length of stay, and cost.5 With approximately 1000000 PCIs performed annually,6 timely reperfusion is a necessary intervention as the mortality rate increases by 7.5% for every 30-minute delay beyond the 90-minute window from the time of arrival to the hospital to balloon inflation in the cardiac catheterization department.7,8

To encourage providers to meet the 90-minute window for patients with AMI, public reporting of AMI outcomes was implemented in some states as a policy to improve cardiac care. Public reporting began when providers and hospitals were required to disclose coronary artery bypass graft (CABG) surgery data in the Society of Thoracic Surgeons Adult Cardiac Surgery Database.9,10 Pennsylvania became the first state in 1986 to implement public reporting, followed by New York in 1989.9 The implementation of public reporting in New York was accompanied by a 41% decline in the CABG mortality rate.11 However, similar declines in mortality have been observed in neighboring states without public reporting legislation in place.7 Conversely, public reporting in New York may have resulted in risk-aversive behaviors demonstrated in CABG surgery causing the sicker patients to be excluded from necessary care and consequently seeking treatment elsewhere.12,13

Over the last 20 years, Massachusetts, New Jersey, and Washington implemented public reporting legislation mandating providers to report whether a patient with AMI receives timely reperfusion therapy through a PCI within a 90-minute window. Therefore, only 4 states in the United States mandate this process for the population with AMI. In addition to state legislation, the National Cardiovascular Data Registry Cath/PCI registry, which also collects PCI data supported by the American College of Cardiology, represents approximately 2400 hospitals; however, hospital participation in public reporting of their National Cardiovascular Data Registry data is voluntary and only available at the hospital level.14

Proponents of public reporting for AMI outcomes aim to improve care by holding providers and organizations accountable for receiving a PCI, resulting in better clinical outcomes for patients with AMI.6 Therefore, examining the evidence on whether public reporting improves outcomes for patients with AMI, who may or may not have undergone an intervention such as PCI, is needed and timely. This systematic review examines studies that evaluate the outcomes of public reporting for patients with AMI, specifically for those who received a PCI. To conduct the review systematically, the following Population-Intervention-Comparison-Outcome question was asked: “In patients with an AMI, what is the effect of the presence of public reporting legislation on whether or not a patient receives a PCI?”

Back to Top | Article Outline


Search Strategy

Wolters Kluwer's Ovid (EMBASE and MEDLINE), Academic Search Premier, Google Scholar, and PubMed were searched from 1995 through August 2017. This decision was deliberate because public reporting legislation was implemented in 1995.9 The Cochrane Database of Systematic Reviews and the Joanna Briggs Institute Database of Systematic Reviews and Implementations Reports were searched to ensure that no existing systematic reviews have been published. The following search terms were used in combination with “public reporting”: “cardiac outcomes,” “myocardial infarction,” “coronary artery bypass graft,” “quality patient care,” and “percutaneous coronary intervention.” The inclusion criteria for studies were ones that were written in English, used a quantitative design, and were published in a peer-reviewed journal. In addition, each study examined the outcome for whether a patient received a PCI during hospitalization for an AMI. Other clinical outcomes included CABG, cardiogenic shock, tamponade, and mortality. The titles, abstracts, and reference lists were screened to identify additional studies. Two authors assessed potential studies, and any disagreements were resolved through a discussion with a third author who provided cardiac care expertise for patients with AMI, which served to clarify the inclusion criteria.

Back to Top | Article Outline

Assessment of Methodological Quality

Methodological quality was assessed using the “Joanna Briggs Institute Critical Appraisal Checklist for Analytical Cross Sectional Studies.”15 This instrument included an 8-question checklist that could be answered by “yes,” “no,” “unclear,” or “not applicable.” A quality threshold score was determined, in which 5 of the 8 questions (62.5%) had to be answered with a “yes” to deem the research of sufficient quality for the review.

Back to Top | Article Outline

Data Extraction

Data were extracted independently using the “Joanna Briggs Institute Data Extraction Form for Experimental/Observational Studies.”15 This instrument allows researchers to aggregate relevant information from each study by providing questions for researchers to extract data. The following data were extracted: study design, participants, sample size and characteristics, data sources, analysis, outcomes, and results of the study.

Back to Top | Article Outline


Study Selection

A total of 421 studies were identified through systematically searching and examining reference lists of 2 descriptive articles.13,16 A Preferred Reporting Items for Systematic Reviews and Meta-Analyses17 flow diagram outlines the study selection process (Figure 1). After screening, there were 24 full-text articles that met the inclusion criteria and were assessed for eligibility. After excluding 5 studies, 19 studies underwent initial appraisal. After further critique, 9 studies were eliminated and 10 studies were included in the review.



Back to Top | Article Outline

Methodological Quality

All 10 studies were methodologically strong with a range from 6 to 8 questions answerable with a “yes” (Figure 2). Only 2 of the studies were unclear on how they defined their inclusion criteria for the sample.18,19 All studies provided a comprehensive description of the study participants, setting, and data sources. The studies also clearly described public reporting and potential confounders, including patient demographics and comorbidities that could contribute to adverse outcomes for patients with AMI. Two research teams did not clearly state that they adjusted for the confounding variables in their analysis.19,20 All studies provided clear descriptions of their outcomes and were sufficiently able to measure and analyze these outcomes with appropriate statistical analyses.



Back to Top | Article Outline

Characteristics of Included Studies

Study Designs and Samples

Of the 10 studies included in the review, 9 research teams conducted a secondary data analysis of large data sets6,18–25 and only 1 team conducted a randomized clinical trial (Table 1).26 In the randomized clinical trial, 86 hospitals were randomized, but not blinded, to receive either an early or a delayed report for how they performed on 12 AMI process measures.26 Eight studies were conducted in the United States,6,18–23,25 1 study was conducted in Canada,26 and the other was conducted in Italy.24 Sample sizes were large (range, 545–1340213 patients) representing several hospitals. The secondary data sets (ie, registries) varied. Two research teams used the same sources, the National Cardiovascular Data CathPCI Registry and the National Inpatient Sample; however, the years of the included sample varied.6,18,22,25



Back to Top | Article Outline

Level of Analysis and Statistical Techniques

All 10 studies conducted patient level analyses and risk-adjusted their statistical models to account for differences in patient severity. In addition, 4 research teams explicitly stated that they accounted for clustering of patients within hospitals,6,18,23,25 because failure to account for intrahospital correlation (ie, clustering in which patients in the same hospital may present the same) would exaggerate the number of independent observations and impair the precision of the resulting estimates.27 Three research teams used propensity score matching to address any baseline differences between patients in nonreporting areas compared with reporting areas and used logistic regression to calculate the odds of death.18,21,22

Back to Top | Article Outline

Included Study Results

Percutaneous Coronary Intervention

Among the 10 studies, 5 research teams found that patients in public reporting areas were less likely to receive a PCI compared with patients in reporting areas.19,21–23,25 Only 1 research team found that public reporting would increase the proportion of patients treated with PCI.24 Two research teams found some beneficial effects in which public reporting increased the proportion of patients treated with PCI; however, these teams also found that, in areas of public reporting, fewer high-risk patients underwent PCI.6,18 The odds of an appropriate PCI was greater in public reporting areas than in non–public reporting areas.18 Only 2 studies included CABG as an outcome (in addition to PCI21,22) indicative of the change in practice from CABG to PCI as an intervention for patients with AMI.

Back to Top | Article Outline

All 10 studies examined patient mortality (ie, in-hospital or 30-day) as an outcome. Two teams found that patients had lower in-hospital mortality after the implementation of public reporting, but only if these patients received a PCI.6,18 This was in contrast to 2 teams that found no difference in mortality despite receiving a PCI.22,23 In the randomized clinical trial, 30-day mortality rates were 2.5% lower in hospitals that received reporting information earlier.26 One research team found that in-hospital mortality was higher in public reporting areas compared with non–public reporting areas,25 and another team found that public reporting resulted in a decreased risk of mortality for hospitals that accept sicker patients.20 The remaining 3 teams found no significant relationship between public reporting and mortality.19,21,24

Back to Top | Article Outline
Other Clinical Outcomes

Three studies examined other clinical outcomes for the population with AMI.6,18,26 One team found that adverse clinical outcomes including having a complication, bleeding, needing a blood transfusion, or contrast-induced nephropathy were lower in a public reporting state compared with a non–public reporting state.18 Whereas the other team found that public reporting had no significant improvement in the process of care indicators for patients with AMI,26 1 team examined the association between public reporting and readmissions and found that patients in public reporting states who had a PCI were more likely to be readmitted at 180 days.6

Back to Top | Article Outline


On the basis of our finding of the systematic review, there is strong, methodological evidence that mandated public reporting does not improve care for patients with AMI. After adjusting for patient severity, there was no significant relationship between public reporting and patient mortality. Two research teams found that mortality was in fact higher in public reporting areas compared with nonreporting areas21,25 and can be explained as providers being fearful of conducting an intervention on high-risk patients.20 Additional research also suggests that public reporting may hinder physicians in provide lifesaving care for the most critical patients.23 Specifically for patients with AMI with ST-segment elevation myocardial infarction, mortality in public reporting states was higher, and once these patients received a PCI, the mortality rate decreased.28 Therefore, avoiding to perform a PCI on a high-risk patient may also result in mortality.

Although evidence in this review does not suggest that public reporting improved care for the patient with AMI, public reporting may have some beneficial outcomes (Table 2). For example, reporting may encourage healthcare providers to keep current with evidence-based guidelines. In a survey of 150 New York state cardiothoracic surgeons, public reporting of information among New York surgeons initiated a dialogue between surgeons and cardiologists, and their patients.29 Although the same research team reported that most (cardiothoracic) surgeons (70%) did not report a change in practice,29 opening the dialogue about treatment options and provider awareness may improve patient care. Furthermore, it may bring attention to providers of the necessary interventions for patients with AMI.



Another possible benefit of public reporting may result from providers being attuned that their clinical outcomes are being recorded. Outcomes for AMI are often measured by real-time clinical data reported by the practitioners and submitted to national databases. The Hawthorne effect, where providers may change behavior when they know they are being “watched,” may ensure that they meet the standard of care. In a study of 5 intensive care units in 1 university hospital, researchers found that, when providers were “watched,” there was a 55% increase in compliance of hand hygiene.30 Therefore, it is plausible that this effect may encourage providers to follow the standard of care for patients with AMI.

A concern with public reporting is the ambivalence and potential additional burden placed on an already stretched healthcare provider. In a recent survey of 228 providers at 7 ambulatory care clinics and 3 public health agencies, researchers found that barriers of publicly reporting included uncertainty about who was responsible for reporting, uncertainty about how reports were used, and lack of clarity about reporting requirements.31 Furthermore, providers do not often receive feedback from the reports, which may result in noncompliance to complete reports.

In addition to provider concerns, the value of public reporting remains questionable for the patient as well. Evidence suggests that publicly available information is not used as a determinant in making healthcare decisions.32 Furthermore, patients rarely search for publicly available information and, if they find it, may not understand it, nor trust the data.32 Therefore, public reporting, although initiated to improve transparency of data for patients, may have resulted in adverse outcomes, especially for the sickest patients with AMI.

Back to Top | Article Outline

Practice and Research Implications

To address providers avoiding PCI on high-risk patients, hospital administrators may want to allay fears of penalization from reports. In addition, to support providers in completing reports, state agencies should provide outreach programs to improve provider perceptions regarding the importance of timely and complete clinical data.31 Furthermore, current evidence suggests that Yelp ratings are reliable for comparing hospital quality.33 Therefore, hospital administrators may want to encourage collaborations with official public reporting agencies. For example, in April 2017, the California Health Care Foundation partnered with Yelp to summarize quality measures collected from Hospital Compare and aggregate them alongside the patient and user-generated reviews.33

To decrease the burden of reporting on providers, research initiatives should focus on investing in systems to streamline public reporting, such as using standardized computer-based platforms. In a survey of providers, respondents spent less time collecting and entering infection data into a computer, as compared with entering them manually.34 Research implications also include integrating public reporting data with clinical data sets. This integration of administrative data with hospital-specific outcome data may provide opportunities for both clinicians and researchers to evaluate quality process measures. For example, there are current initiatives for hospitals to build clinical data warehouses that can provide useful information about patient care to allow providers to slow the progression of a disease.35

Back to Top | Article Outline


Although we attempted to be exhaustive in our search, some studies pertaining to public reporting and AMI outcomes may have been missed. As Figure 1 indicates, we first excluded articles by reading titles and abstracts, which may have decreased the number of studies included in the review; however, being cognizant that only 4 states have mandated public reporting legislations in place for patients with AMI, we expected a small sample of studies on this topic. In addition, although we established high interrater agreement and used validated extraction and quality assessment instruments, some scores may have been subject to experience levels of the researchers. Furthermore, the task to synthesize a large amount of evidence and present a smaller subset of conclusions is an additional limitation because all details of each study cannot be presented.

Back to Top | Article Outline


Public reporting is used by local, federal, and state governments, as well as healthcare institutions, to benchmark on performance measures such as quality, safety, and cost in delivering care to the patient with AMI. These policies, despite their questionable value, will most likely continue to exist. Therefore, the challenge is to encourage providers not to fear public reporting and rather support providers in the process, which may ultimately improve care of the patient with AMI.

Back to Top | Article Outline
What's New and Important?
  • Legislations requiring public reporting of AMI outcomes were designed to improve patient care; however, this process resulted in unforeseen implications including high-risk patients not receiving timely reperfusion therapy.
  • There is no statistically significant relationship between public reporting and decreased mortality. In fact, some evidence suggests that mortality rates are higher in public reporting areas.
  • Public reporting has the potential to improve quality because clinicians may become more attuned to the standards of care for the patient with AMI.
Back to Top | Article Outline


1. American Heart Association. Heart disease and stroke statistics 2017: at-a-glance. 2017. Accessed September 15, 2017.
2. Agency for Healthcare Research and Quality (AHRQ). HCUPnet. Accessed September 15, 2017.
3. Torio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006.
4. Gerber TC, Kontos MC, Kantor B. Emergency department assessment of acute-onset chest pain: contemporary approaches and their consequences. Mayo Clin Proc. 2010;85(4):309–313.
5. Stukel TA, Alter DA, Schull MJ, Ko DT, Li P. Association between hospital cardiac management and outcomes for acute myocardial infarction patients. Med Care. 2010;48(2):157–165.
6. Cavender MA, Joynt KE, Parzynski CS, et al. State mandated public reporting and outcomes of percutaneous coronary intervention in the United States. Am J Cardiol. 2015;115(11):1494–1501.
7. Meadows-Pitt M, Fields W. The impact of prehospital 12-lead electrocardiograms on door-to-balloon time in patients with ST-elevation myocardial infarction. J Emerg Nurs. 2014;40(3):e63–e68.
8. Zanini R, Aroldi M, Bonatti S, et al. Impact of prehospital diagnosis in the management of ST elevation myocardial infarction in the era of primary percutaneous coronary intervention: reduction of treatment delay and mortality. J Cardiovasc Med (Hagerstown). 2008;9(6):570–575.
9. Ritley DPR. The State of Cardiovascular Revascularization Outcomes Reporting. Davis, CA: University of California, Davis, Center for Healthcare Policy and Research; 2011.
10. Hannan EL, Cozzens K, Samadashvili Z, et al. Appropriateness of coronary revascularization for patients without acute coronary syndromes. J Am Coll Cardiol. 2012;59(21):1870–1876.
11. Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA. 1998;280(11):1000–1005.
12. Marshall MN, Shekelle PG, Leatherman S, Brook RH. The public release of performance data: what do we expect to gain? A review of the evidence. JAMA. 2000;283(14):1866–1874.
13. Shahian DM, Edwards FH, Jacobs JP, et al. Public reporting of cardiac surgery performance: part 1—history, rationale, consequences. Ann Thorac Surg. 2011;92(3 suppl):S2–S11.
14. McDaniel MC, Rab ST. Public reporting in ST segment elevation myocardial infarction. Interv Cardiol Clin. 2016;5(4):561–567.
15. The Joanna Briggs Institute. 2014 Reviewers' Manual. Accessed June 28, 2018.
16. Shahian DM, Edwards FH, Jacobs JP, et al. Public reporting of cardiac surgery performance: part 2—implementation. Ann Thorac Surg. 2011;92(3 suppl):S12–S23.
17. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
18. Boyden TF, Joynt KE, McCoy L, et al. Collaborative quality improvement vs public reporting for percutaneous coronary intervention: a comparison of percutaneous coronary intervention in New York vs Michigan. Am Heart J. 2015;170(6):1227–1233.
19. Moscucci M, Eagle KA, Share D, et al. Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases. J Am Coll Cardiol. 2005;45(11):1759–1765.
20. McCabe JM, Joynt KE, Welt FG, Resnic FS. Impact of public reporting and outlier status identification on percutaneous coronary intervention case selection in Massachusetts. JACC Cardiovasc Interv. 2013;6(6):625–630.
21. Apolito RA, Greenberg MA, Menegus MA, et al. Impact of the New York State cardiac surgery and percutaneous coronary intervention reporting system on the management of patients with acute myocardial infarction complicated by cardiogenic shock. Am Heart J. 2008;155(2):267–273.
22. Bangalore S, Guo Y, Xu J, et al. Rates of invasive management of cardiogenic shock in New York before and after exclusion from public reporting. JAMA Cardiol. 2016;1(6):640–647.
23. Joynt KE, Blumenthal DM, Orav EJ, Resnic FS, Jha AK. Association of public reporting for percutaneous coronary intervention with utilization and outcomes among Medicare beneficiaries with acute myocardial infarction. JAMA. 2012;308(14):1460–1468.
24. Renzi C, Asta F, Fusco D, Agabiti N, Davoli M, Perucci CA. Does public reporting improve the quality of hospital care for acute myocardial infarction? Results from a regional outcome evaluation program in Italy. Int J Qual Health Care. 2014;26(3):223–230.
25. Waldo SW, McCabe JM, O'Brien C, Kennedy KF, Joynt KE, Yeh RW. Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction. J Am Coll Cardiol. 2015;65(11):1119–1126.
26. Tu JV, Donovan LR, Lee DS, et al. Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA. 2009;302(21):2330–2337.
27. Kuttner R. The risk-adjustment debate. N Engl J Med. 1998;339(26):1952–1956.
28. Henry T. Controversies in the Management of STEMI: An Issue of the Interventional Cardiology Clinics. 1st ed. Philadelphia, PA: Elsevier; 2016.
29. Burack JH, Impellizzeri P, Homel P, Cunningham JN Jr. Public reporting of surgical mortality: a survey of New York State cardiothoracic surgeons. Ann Thorac Surg. 1999;68(4):1195–1200.
30. Eckmanns T, Bessert J, Behnke M, Gastmeier P, Ruden H. Compliance with antiseptic hand rub use in intensive care units: the Hawthorne effect. Infect Control Hosp Epidemiol. 2006;27(9):931–934.
31. Revere D, Hills RH, Dixon BE, Gibson PJ, Grannis SJ. Notifiable condition reporting practices: implications for public health agency participation in a health information exchange. BMC Public Health. 2017;17(1):247.
32. Faber M, Bosch M, Wollersheim H, Leatherman S, Grol R. Public reporting in health care: how do consumers use quality-of-care information? A systematic review. Med Care. 2009;47(1):1–8.
33. Howard P, Feyman Y. Yelp for Health: Using the Wisdom of Crowds to Find High-Quality Hospitals. The Manhattan Institute; 2017. Accessed June 28, 2018.
34. Vostok J, Lapsley W, McElroy N, et al. Assessment of the burden of mandatory reporting of health care-associated infection using the National Healthcare Safety Network in Massachusetts. Am J Infect Control. 2013;41(5):466–468.
35. Karami M, Rahimi A, Shahmirzadi AH. Clinical data warehouse: an effective tool to create intelligence in disease management. Health Care Manag. 2017;36(4):380–384.

myocardial infarction; percutaneous coronary intervention

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved